# The Effect of Pyridoxamine Supplementation on Microvascular Function in Type 2 Diabetes

> **NCT06376240** · NA · COMPLETED · sponsor: **Maastricht University Medical Center** · enrollment: 40 (actual)

## Conditions studied

- Type 2 Diabetes
- Microvascular Function
- Retinopathy, Diabetic
- Nephropathy, Diabetic
- Neuropathy, Diabetic

## Interventions

- **DIETARY_SUPPLEMENT:** Pyridoxamine 300mg per day
- **OTHER:** Placebo 300mg placebo per day

## Key facts

- **NCT ID:** NCT06376240
- **Lead sponsor:** Maastricht University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-21
- **Primary completion:** 2026-03-13
- **Final completion:** 2026-03-13
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2026-04-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06376240

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06376240, "The Effect of Pyridoxamine Supplementation on Microvascular Function in Type 2 Diabetes". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06376240. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*